Elevated FGF23 levels have been documented at the early stage of chronic kidney disease (CKD)5, and increased FGF23 level is associated with CKD progression, risk for initiation of dialysis, higher prevalence of cardiovascular disease (CVD), and mortality in patients with CKD6–9. Here, FGF23 is linked to chronic kidney disease.